Rapid Micro Biosystems, Inc. RPID
0.74 USD 0.00 (-0.31%)
Regular-session close
0.74 0.00 +0.48%
After hours · Nov 19, 4:00 PM ET
0.7353 Day range 0.7366
0.58 52-week range 4.94
- YTD
- -74.64%
- 1 year
- -83.14%
Analyst view
Price target (mean) 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.225 | -0.24 – -0.21 | -0.26 | +13.5% | 7.60M | +19.9% | 2 |
| Next quarter | -0.21 | -0.21 – -0.21 | -0.31 | +32.3% | 6.70M | +19.4% | 1 |
| Current year | -1.08 | -1.09 – -1.06 | -1.22 | +11.9% | 27.45M | +21.9% | 2 |
| Next year | -0.895 | -0.91 – -0.88 | -1.08 | +16.7% | 32.80M | +19.5% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 7, 2023 | Morgan Stanley | Reiterated | — | Equal-Weight |
| Aug 16, 2022 | JP Morgan | Downgrade | Overweight | Neutral |
| May 11, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 7, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 15, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 15, 2021 | Morgan Stanley | Maintained | — | Equal-Weight |
| Aug 9, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Aug 9, 2021 | Morgan Stanley | Initiated | — | Equal-Weight |
| Aug 9, 2021 | Stifel | Initiated | — | Buy |
| Aug 9, 2021 | JP Morgan | Initiated | — | Overweight |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
